Literature DB >> 28193659

Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

George Koutsoudakis1, Alexia Paris de León1, Carolina Herrera2, Marcus Dorner2, Gemma Pérez-Vilaró1, Sébastien Lyonnais3, Santiago Grijalvo4, Ramon Eritja4, Andreas Meyerhans5,6, Gilles Mirambeau3,7, Juana Díez8.   

Abstract

A hepatitis C virus (HCV) epidemic affecting HIV-infected men who have sex with men (MSM) is expanding worldwide. In spite of the improved cure rates obtained with the new direct-acting antiviral drug (DAA) combinations, the high rate of reinfection within this population calls urgently for novel preventive interventions. In this study, we determined in cell culture and ex vivo experiments with human colorectal tissue that lipoquads, G-quadruplex DNA structures fused to cholesterol, are efficient HCV pangenotypic entry and cell-to-cell transmission inhibitors. Thus, lipoquads may be promising candidates for the development of rectally applied gels to prevent HCV transmission.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  DNA G-quadruplex structures; HCV cell-to-cell inhibitor; HCV entry inhibitor; HCV pangenotypic inhibitor; antiviral treatment; oligonucleotide-cholesterol conjugates

Mesh:

Substances:

Year:  2017        PMID: 28193659      PMCID: PMC5404530          DOI: 10.1128/AAC.02354-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  76 in total

1.  Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study.

Authors:  Nicola Richardson-Harman; Christine Mauck; Ian McGowan; Peter Anton
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-20       Impact factor: 2.205

Review 2.  G-quadruplex structures and their interaction diversity with ligands.

Authors:  Sulin Zhang; Yanling Wu; Wen Zhang
Journal:  ChemMedChem       Date:  2014-04-11       Impact factor: 3.466

3.  Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.

Authors:  Jannick Prentoe; Tanja B Jensen; Philip Meuleman; Stéphanie B N Serre; Troels K H Scheel; Geert Leroux-Roels; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.

Authors:  J R Conejo; J Kleeff; A Koliopanos; K Matsuda; Z W Zhu; H Goecke; N Bicheng; A Zimmermann; M Korc; H Friess; M W Büchler
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

5.  Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Authors:  Heidi Barth; Christiane Schafer; Mohammed I Adah; Fuming Zhang; Robert J Linhardt; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Toshihiko Toida; Toin H Van Kuppevelt; Erik Depla; Fritz Von Weizsacker; Hubert E Blum; Thomas F Baumert
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

6.  Tissue-specific expression of occludin, zona occludens-1, and junction adhesion molecule A in the duodenum, ileum, colon, kidney, liver, lung, brain, and skeletal muscle of C57BL mice.

Authors:  I Hwang; B S An; H Yang; H S Kang; E M Jung; E B Jeung
Journal:  J Physiol Pharmacol       Date:  2013-02       Impact factor: 3.011

7.  Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption.

Authors:  Raphaële Germi; Jean-Marc Crance; Daniel Garin; Josette Guimet; Hugues Lortat-Jacob; Rob W H Ruigrok; Jean-Pierre Zarski; Emmanuel Drouet
Journal:  J Med Virol       Date:  2002-10       Impact factor: 2.327

8.  The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.

Authors:  Muhammad N Zahid; Marine Turek; Fei Xiao; Viet Loan Dao Thi; Maryse Guérin; Isabel Fofana; Philippe Bachellier; John Thompson; Leen Delang; Johan Neyts; Dorothea Bankwitz; Thomas Pietschmann; Marlène Dreux; François-Loïc Cosset; Fritz Grunert; Thomas F Baumert; Mirjam B Zeisel
Journal:  Hepatology       Date:  2012-12-28       Impact factor: 17.425

9.  Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.

Authors:  Y K Shimizu; M Hijikata; A Iwamoto; H J Alter; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

Authors:  Ian Mcgowan; Ross D Cranston; Kathryn Duffill; Aaron Siegel; Jarret C Engstrom; Alexyi Nikiforov; Cindy Jacobson; Khaja K Rehman; Julie Elliott; Elena Khanukhova; Kaleab Abebe; Christine Mauck; Hans M L Spiegel; Charlene S Dezzutti; Lisa C Rohan; Mark A Marzinke; Hiwot Hiruy; Craig W Hendrix; Nicola Richardson-Harman; Peter A Anton
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

View more
  2 in total

1.  Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes.

Authors:  Anna Clua; Santiago Grijalvo; Namrata Erande; Swati Gupta; Kristina Yucius; Raimundo Gargallo; Stefania Mazzini; Muthiah Manoharan; Ramon Eritja
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

2.  Spectroscopic Properties of Two 5'-(4-Dimethylamino)Azobenzene Conjugated G-Quadruplex Forming Oligonucleotides.

Authors:  Concetta Imperatore; Antonio Varriale; Elisa Rivieccio; Angela Pennacchio; Maria Staiano; Sabato D'Auria; Marcello Casertano; Carlo Altucci; Mohammadhassan Valadan; Manjot Singh; Marialuisa Menna; Michela Varra
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.